Abstract
Among head and neck squamous cell carcinoma (HNSCC), the incidence of oropharyngeal SCC (OPSCC) is increasing in contrast to carcinoma with origin in other subsites. Human papillomavirus (HPV) is now recognized as a significant risk factor of the carcinogenesis of OPSCC. The HPV-related OPSCC patients tend to be relatively young, less exposed to tobacco and alcohol, and have a relatively high socioeconomic status and education level, which is distinct from HPV-unrelated classical OPSCC. The neck metastases tend to be aggressive and cystic. The better response to treatment resulting in improved prognosis of HPV-related OPSCC led to reconsidering the clinical staging and treatment approaches. Clinical trials of treatment deintensification to reduce the acute and late toxicity without compromising efficacy have been conducted. This review of HPV-related OPSCC focuses on current and generally accepted facts regarding the biology, epidemiology, and therapeutic strategy of this new disease entity.
Similar content being viewed by others
References
Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: Globocan. Int J Cancer 127:2893–2917
van Monsjou HS, Balm AJ, van den Brekel MM et al (2010) Oropharyngeal squamous cell carcinoma: a unique disease on the rise? Oral Oncol 46:780–785
Mignogna MD, Fedele S, Lo Russo L (2004) The World Cancer Report and the burden of oral cancer. Eur J Cancer Prev 13:139–142
Cancer Statistics in Japan (2009) Foundation for promotion of cancer research. http://www.fpcr.or.jp/publication/statistics.html
Japan Society for Head and Neck Cancer Registry Committee (2015) Report of head and neck cancer registry of Japan Clinical statistics of registered patients, 2013. Jpn J Head Neck Cancer 41(suppl):1–14
Chaturvedi AK, Engels EA, Pfeiffer RM et al (2011) Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29:4294–4301
Sturgis EM, Ang KK (2011) The epidemic of HPV-associated oropharyngeal cancer is here: is it time to change our treatment paradigms? J Natl Compr Cancer Netw 9:665–673
Sturgis EM, Cinciripini PM (2007) Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers? Cancer (Phila) 110:1429–1435
Gillison ML, Koch WM, Capone RB et al (2000) Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92:709–720
D’Souza G, Kreimer AR, Viscidi R et al (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356:1944–1956
Chaturvedi AK, Engels EA, Anderson WF et al (2008) Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States. J Clin Oncol 26:612–619
Dürst M, Gissmann L, Ikenberg H et al (1983) A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80:3812–3815
zur Hausen H (2009) The search for infectious causes of human cancers: where and why. Virology 392:1–10
Stubenrauch F, Laimins LA (1999) Human papillomavirus life cycle: active and latent phases. Semin Cancer Biol 9:379–386
Kreimer AR, Clifford GM, Boyle P et al (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14:467–475
Hama T, Tokumaru Y, Fujii M et al (2014) Prevalence of human papillomavirus in oropharyngeal cancer: a multicenter study in Japan. Oncology 87:173–182
Stanley MA, Pett MR, Coleman N (2007) HPV: from infection to cancer. Biochem Soc Trans 35:1456–1460
Moody CA, Laimins LA (2010) Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 10:550–560
Jeon S, Lambert PF (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci USA 92:1654–1658
Ragin CC, Reshmi SC, Gollin SM (2014) Mapping and analysis of HPV16 integration sites in a head and neck cancer cell line. Int J Cancer 110:701–709
Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22
Ndiaye C, Mena M, Alemany L et al (2014) HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol 15:1319–1331
Allen CT, Lewis JS Jr, El–Mofty SK et al (2010) Human papillomavirus and oropharynx cancer: biology, detection and clinical implications. Laryngoscope 120:1756–1772
https://clinicaltrials.gov/ct2/show/NCT01874171?term=De-ESCALaTE&rank=1
https://clinicaltrials.gov/ct2/show/NCT01855451?term=TROG12.01&rank=1
https://clinicaltrials.gov/ct2/show/NCT01898494?term=NCT01898494&rank=1
https://clinicaltrials.gov/ct2/show/NCT01687413?term=NCT01687413&rank=1
Ang KK, Harris J, Wheeler R et al (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363:24–35
Perez-Ordonez B, Beauchemin M, Jordan RC (2006) Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol 59:445–453
Klussmann JP, Gültekin E, Weissenborn SJ et al (2003) Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162:747–753
Begum S, Cao D, Gillison M et al (2005) Tissue distribution of human papillomavirus 16 DNA integration in patients with tonsillar carcinoma. Clin Cancer Res 11:5694–5699
Fakhry C, Westra WH, Li S et al (2008) Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 100:261–269
Licitra L, Perrone F, Bossi P et al (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24:5630–5636
Shi W, Kato H, Perez-Ordonez B et al (2009) Comparative prognostic value of HPV16 E6 mRNA compared with in situ hybridization for human oropharyngeal squamous carcinoma. J Clin Oncol 27:6213–6221
Smeets SJ, Hesselink AT, Speel EJ et al (2007) A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen. Int J Cancer 121:2465–2472
Chaturvedi AK, Anderson WF, Lortet-Tieulent J et al (2013) Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers. J Clin Oncol 31:4550–4559
Upile NS, Shaw RJ, Jones TM et al (2014) Squamous cell carcinoma of the head and neck outside the oropharynx is rarely human papillomavirus related. Laryngoscope 124:2739–2744
Mineta H, Ogino T, Amano HM et al (1998) Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma. Anticancer Res 18:4765–4768
Mizumachi T, Kano S, Sakashita T et al (2013) Improved survival of Japanese patients with human papillomavirus-positive oropharyngeal squamous cell carcinoma. Int J Clin Oncol 18:824–828
Maruyama H, Yasui T, Ishikawa-Fujiwara T et al (2014) Human papillomavirus and p53 mutations in head and neck squamous cell carcinoma among Japanese population. Cancer Sci 105:409–417
Saito Y, Yoshida M, Ushiku T et al (2013) Prognostic value of p16 expression and alcohol consumption in Japanese patients with oropharyngeal squamous cell carcinoma. Cancer (Phila) 119:2005–2011
Gillison ML, Chaturvedi AK, Anderson WF et al (2015) Epidemiology of human papillomavirus-positive head and neck squamous cell carcinoma. J Clin Oncol 33:3235–3242
Elrefaey S, Massaro MA, Chiocca S et al (2014) HPV in oropharyngeal cancer: the basics to know in clinical practice. Acta Otorhinolaryngol Ital 34:299–309
de Martel C, Ferlay J, Franceschi S et al (2012) Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol 13:607–615
Urban D, Corry J, Rischin D (2014) What is the best treatment for patients with human papillomavirus-positive and -negative oropharyngeal cancer? Cancer 120:1462-1470
Benard VB, Johnson CJ, Thompson TD et al (2008) Examining the association between socioeconomic status and potential human papillomavirus associated cancers. Cancer (Phila) 113:2910–2918
Markowitz LE, Sternberg M, Dunne EF et al (2009) Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003–2004. J Infect Dis 200:1059–1067
Darwich L, Canadas MP, Videla S et al (2014) Can Ruti HIV-HPV Team. Oral human papillomavirus type-specific infection in HIV-infected men: a prospective cohort study among men who have sex with men and heterosexual men. Clin Microbiol Infect 20:O585–O589
Beachler DC, D’Souza G, Sugar EA et al (2013) Natural history of anal vs. oral HPV infection in HIV-infected men and women. J Infect Dis 208:330–339
Slaughter DP, Southwick HW, Smejkal W (1953) Cancer field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer (Phila) 6:963–968
Huang SH, Perez-Ordonez B, Liu FF et al (2012) Atypical clinical behaviour of p16-confirmed HPV-related oropharyngeal squamous cell carcinoma treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 82:276–283
Goldenberg D, Begum S, Westra WH et al (2008) Cystic lymph node metastasis in patients with head and neck cancer: an HPV-associated phenomenon. Head Neck 30:898–903
Yasui T, Morii E, Yamamoto Y et al (2014) Human papillomavirus and cystic node metastasis in oropharyngeal cancer and cancer of unknown primary origin. PLoS One 9:e95364
McQuone SJ, Eisele DW, Lee DJ et al (1998) Occult tonsillar carcinoma in the unknown primary. Laryngoscope 108:1605–1610
Ebisumoto K, Okami K, Sakai A et al (2016) Successful detection of a minute tonsillar cancer lesion on transoral examination with narrow band imaging: a report of 2 cases. Head Neck 38:E2421–E2424
Koch WM, Batti N, Williams MF et al (2001) Oncologic rationale for bilateral tonsillectomy in head and neck squamous cell carcinoma of unknown primary source. Otolaryngol Head Neck Surg 124:331–333
Cianchetti M, Mancuso AA, Amdur RJ et al (2009) Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope 119:2348–2354
Kobayashi K, Saito Y, Omura G et al (2014) Clinical features of human papilloma virus-related head and neck squamous cell carcinoma of an unknown primary site. ORL J Otorhinolaryngol Relat Spec 76:137–146
Begum S, Gillison ML, Ansari-Lari MA (2003) Detection of human papillomavirus in cervical lymph nodes: a highly effective strategy for localizing site of tumor origin. Clin Cancer Res 9:6469–6475
El-Mofty SK, Zhang MQ, Davila RM (2008) Histologic identification of human papillomavirus (HPV)-related squamous cell carcinoma in cervical lymph nodes: a reliable predictor of the site of an occult head and neck primary carcinoma. Head Neck Pathol 2:163–168
Nakahara S, Yasui T, Takenaka Y et al (2014) Synchronous bilateral tonsillar carcinomas associated with human papillomavirus. Auris Nasus Larynx 41:109–112
Kothari P, Randhawa PS, Farrell R (2008) Role of tonsillectomy in the search for a squamous cell carcinoma from an unknown primary in the head and neck. Br J Oral Maxillofac Surg 46:283–287
Rasband-Lindquist A, Shnayder Y, O’Neil M (2016) Synchronous bilateral tonsillar squamous cell carcinoma related to human papillomavirus: two case reports and a brief review of the literature. Ear Nose Throat J 95:E30–E34
Waltonen JD, Ozer E, Hall NC et al (2009) Metastatic carcinoma of the neck of unknown primary origin: evolution and efficacy of the modern workup. Arch Otolaryngol Head Neck Surg 135:1024–1029
Marur S, D’Souza G, Westra WH et al (2010) HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 11:781–789
Chung CH, Gillison ML (2009) Human papillomavirus in head and neck cancer: its role in pathogenesis and clinical implications. Clin Cancer Res 15:6758–6762
Rischin D, Young RJ, Fisher R et al (2010) Prognostic significance of p16INK4A and human papillomavirus in patients with oropharyngeal cancer treated on TROG 02.02 phase III trial. J Clin Oncol 28:4142–4148
Lassen P, Eriksen JG, Krogdahl A et al (2010) The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomized DAHANCA 6&7 trial. Radiother Oncol 100:49–55
Posner M, Lorche J, Goloubeva O et al (2010) Survival and human papillomavirus in oropharynx cancer in TAX324: a subset analysis from an international phase III trial. Ann Oncol 22:1071–1077
O’Rorke MA, Ellison MV, Murray LJ et al (2012) Human papillomavirus related head and neck cancer survival: a systematic review and meta-analysis. Oral Oncol 48:1191–1201
Stransky N, Egloff AM, Tward AD et al (2011) The mutational landscape of head and neck squamous cell carcinoma. Science 333:1157–1160
Klussmann JP, Mooren JJ, Lehnen M et al (2009) Genetic signatures of HPV-related and unrelated oropharyngeal carcinoma and their prognostic implications. Clin Cancer Res 15:1779–1786
Lindel K, Beer KT, Laissue J et al (2001) Human papillomavirus positive squamous cell carcinoma of the oropharynx: a radiosensitive subgroup of head and neck carcinoma. Cancer (Phila) 92:805–813
Vu HL, Sikora AG, Fu S et al (2010) HPV-induced oropharyngeal cancer, immune response and response to therapy. Cancer Lett 288:149–155
Gillison ML, Zhang Q, Jordan R et al (2012) Tobacco smoking and increased risk of death and progression for patients with p16-positive and p16-negative oropharyngeal cancer. J Clin Oncol 30:2102–2111
Huang SH, Xu W, Waldron J et al (2015) Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas. J Clin Oncol 33:836–845
O’Sullivan B, Huang SH, Su J, et al. (2016) Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal Cancer Network for Staging (ICON-S): a multicentre cohort study. Lancet Oncol 26:S1470–S2045
https://clinicaltrials.gov/ct2/show/NCT01084083?term=NCT01084083&rank=1
Chera BS, Amdur RJ, Tepper J et al (2015) Phase 2 trial of de-intensified chemoradiation therapy for favorable-risk human papillomavirus-associated oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys 93:976–985
https://clinicaltrials.gov/ct2/show/NCT01706939?term=NCT01706939&rank=1
Morimoto A, Ueda Y, Egawa-Takata T et al (2015) Effect on HPV vaccination in Japan resulting from news report of adverse events and suspension of governmental recommendation for HPV vaccination. Int J Clin Oncol 20:549–555
Hanley SJ, Yoshioka E, Ito Y et al (2015) HPV vaccination crisis in Japan. Lancet 385:2571
Dornbusch HJ, Stiris T, Del Torso S et al (2015) Human papillomavirus vaccination crisis in Japan. J Paediatr Child Health 51:1146–1147
Isaranuwatchai W, Graham DM, Siu LL et al (2014) Could the human papillomavirus vaccination be cost-effective in males for the prevention of oropharyngeal cancer? Expert Rev Pharmacoecon Outcomes Res 14(6):763–765
Kim JJ, Goldie SJ (2009) Cost effectiveness analysis of including boys in a human papillomavirus vaccination programme in the United States. BMJ 339:b3884
Elbasha EH, Dasbach EJ (2010) Impact of vaccinating boys and men against HPV in the United States. Vaccine 28:6858–6867
Graham DM, Isaranuwatchai W, Habbous S et al (2015) A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer. Cancer (Phila) 121:1785–1792
Guo T, Eisele DW, Fakhry C (2016) The potential impact of prophylactic human papillomavirus vaccination on oropharyngeal cancer. Cancer (Phila) doi: 10.1002/cncr.29992. (epub ahead of print)
Herrero R, Quint W, Hildesheim A et al (2013) Reduced prevalence of oral human papillomavirus (HPV) 4 years after bivalent HPV vaccination in a randomized clinical trial in Costa Rica. PLoS One 8:e68329
Beachler DC, Kreimer AR, Schiffman M, et al; Costa Rica HPV Vaccine Trial (CVT) Group (2016) Multisite HPV16/18 vaccine efficacy against cervical, anal, and oral HPV infection. J Natl Cancer Inst 108:pii djv302
Khwaja SS, Baker C, Haynes W, et al (2016) High E6 gene expression predicts for distant metastasis and poor survival in patients with HPV-positive oropharyngeal squamous cell carcinoma. Int J Radiat Oncol Biol Phys S03606(16)00240-6
Vainshtein JM, Sector ME, Ibrahim M et al (2016) Matted nodes: high distant-metastasis risk and a potential indication for intensification of systemic therapy in human papillomavirus-related oropharyngeal cancer. Head Neck 38(suppl 1):E805–E814
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
I, the author, declare that I have no conflicts of interest.
About this article
Cite this article
Okami, K. Clinical features and treatment strategy for HPV-related oropharyngeal cancer. Int J Clin Oncol 21, 827–835 (2016). https://doi.org/10.1007/s10147-016-1009-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-016-1009-6